Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: Functional characterization and a review of the literature
- 1 April 2009
- journal article
- case report
- Published by Elsevier in Experimental Hematology
- Vol. 37 (4) , 495-503
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradationBlood, 2008
- Functional analysis of single amino‐acid mutations in the thrombopoietin‐receptor Mpl underlying congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 2008
- Congenital amegakaryocytic thrombocytopenia: The diagnostic importance of combining pathology with molecular geneticsPediatric Blood & Cancer, 2008
- Congenital Amegakaryocytic Thrombocytopenia—3 Novel c-MPL Mutations and Their Phenotypic CorrelationsJournal of Pediatric Hematology/Oncology, 2007
- New thrombopoietic growth factorsBlood, 2007
- Congenital amegakaryocytic thrombocytopenia—Report of a newc-mpl gene missense mutationAmerican Journal of Hematology, 2007
- Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytesBlood, 2006
- MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the diseaseHuman Mutation, 2006
- Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 2000
- The physiological response of thrombopoietin (c‐Mpl ligand) to thrombocytopenia in the ratBritish Journal of Haematology, 1999